Search

Search Constraints

You searched for: Author/Creator Cheung, Matthew C.

Search Results

1. A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma. (23rd June 2021)

2. A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Issue 4 (21st March 2019)

3. Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time. (June 2021)

4. Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma. (30th January 2018)

5. Azacitidine in the 'real‐world': an evaluation of 1101 higher‐risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada. (16th May 2018)

7. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Issue 11 (November 2014)

8. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Issue 11 (November 2014)